Tonix Pharmaceuticals acquires pair of FDA-approved migraine products from Upsher-Smith
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive studios to discuss the acquisition of two migraine products...
Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive studios to discuss the acquisition of two migraine products...
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joins Natalie Stoberman from the Proactive newsroom to discuss the recent publication of the company's...
Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial
Mediated recycling • Marketed albumin fusions and conjugates ‒ Levemir ‒ Eperzan / Tanzeum ‒ Victoza ‒ Abraxane ... | June 13, 2023
<iframe src=https://www.youtube.com/embed/1AycYWstVlA></iframe>Tonix Pharmaceuticals CEO Seth Lederman joins Natalie Stoberman from the Proactive studio to discuss the latest results from... | May 31, 2023